Monoclonal antibodies against human aspartyl (asparaginyl) beta-hydroxylase developed by DNA immunization

Hybridoma

Volumn 28, Issue 4, 2009, Pages 251-257

  Xue, Tao ^a   Xue, Xiao Ping ^b   Huang, Qing Sheng ^b   Wei, Li ^a   Sun, Kai ^b   Xue, Tian ^c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

^c NORTHWEST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTYL(ASPARAGINYL)BETA HYDROXYLASE; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY F11; MONOCLONAL ANTIBODY G3; MONOCLONAL ANTIBODY G9; OXYGENASE; PLASMID DNA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BILE DUCT CARCINOMA; BREAST CANCER; CANCER DIAGNOSIS; CASE REPORT; CONTROLLED STUDY; ELECTROFUSION (CELL); ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE TARGETING; GENETIC CODE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; HYBRIDOMA; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY CANCER; LIVER CELL CARCINOMA; LUNG CANCER; MOLECULAR CLONING; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SENSITIVITY AND SPECIFICITY; SPLEEN CELL; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; DNA; HUMANS; HYBRIDOMAS; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOLOGIC TECHNIQUES; MICE; MIXED FUNCTION OXYGENASES; MULTIPLE MYELOMA; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SPLEEN;

MUS;

EID: 68949144555     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2009.0017     Document Type: Article

References (19)

1. Ince N, de la Monte SM, and Wands JR: Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation. Cancer Res 2000;60(5):1261-1266.
2. Jia S, McGinnis K, VanDusen WJ, Burke CJ, Kuo A, Griffin PR, Sardana MK, Elliston KO, Stern AM, and Friedman PA: A fully active catalytic domain of bovine aspartyl (asparaginyl) beta-hydroxylase expressed in Escherichia coli: characterization and evidence for the identification of an active-site region in vertebrate alpha-ketoglutarate-dependent dioxygenases. Proc Natl Acad Sci USA 1994;91(15):7227-7231.
3. Lavaissiere L, Jia S, Nishiyama M, de la Monte S, Stern AM, Wands JR, and Friedman PA: Overexpression of human aspartyl (asparaginyl) beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J Clin Invest 1996;98(6):1313-1323.
4. Feldmann G, Nattermann J, Nischalke HD, Gorschluter M, Kuntzen T, Ahlenstiel G, Gerhardt T, Wolff M, Sauerbruch T, Spengler U, and Dumoulin FL: Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer. Endoscopy 2006;38(6):604-609.
5. Maeda T, Taguchi K, Aishima S, Shimada M, Hintz D, Larusso N, Gores G, Tsuneyoshi M, Sugimachi K, Wands JR, and de la Monte SM: Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma. Cancer Detect Prev 2004;28(5):313-318.
6. Palumbo KS, Wands JR, Safran H, King T, Carlson RI, and de la Monte SM: Human aspartyl (asparaginyl) beta-hydroxylase monoclonal antibodies: potential biomarkers for pancreatic carcinoma. Pancreas 2002;25(1):39-44.
7. Sepe PS, Lahousse SA, Gemelli B, Chang H, Maeda T, Wands JR, and de la Monte SM: Role of the aspartyl-asparaginyl beta-hydroxylase gene in neuroblastoma cell motility. Lab Invest 2002;82(7):881-891.
8. Huang Y, Babiuk LA, and van Drunen Littel-van den Hurk S: Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle. J Gen Virol 2005;86(Pt 4):887-898.
9. Qu B, Rosenberg RN, Li L, Boyer PJ, and Johnston SA: Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease. Hybridoma 2004;61(12):1859-1864.
10. Coller HA, and Coller BS: Statistical analysis of repetitive subcloning by the limiting dilution technique with a view toward ensuring hybridoma monoclonality. Arch Neurol 1983;2(1):91-96.
11. de la Monte SM, Tamaki S, Cantarini MC, Ince N, Wiedmann M, Carter JJ, Lahousse SA, Califano S, Maeda T, Ueno T, D'Errico A, Trevisani F, and Wands JR: Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness. J Hepatol 2006;44(5):971-983.
12. Beatty JD, Beatty BG, and Vlahos WG: Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods 1987;100(1-2):173-179.
13. Gundogan F, Elwood G, Greco D, Rubin LP, Pinar H, Carlson RI, Wands JR, and de la Monte SM: Role of aspartyl-(asparaginyl) beta-hydroxylase in placental implantation: relevance to early pregnancy loss. Hum Pathol 2007;38(1):50-59.
14. Maeda T, Sepe P, Lahousse S, Tamaki S, Enjoji M, Wands JR, and de la Monte SM: Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) beta-hydroxylase suppress migration of cholangiocarcinoma cells. J Hepatol 2003;38(5):615-622.
15. Ho SP, Scully MS, Krauthauser CM, Wexler EJ, Stow MD, Dinchuk JE, Kerr JS, and Friedman PA: Antisense oligonucleotides selectively regulate aspartyl beta-hydroxylase and its truncated protein isoform in vitro but distribute poorly into A549 tumors in vivo. J Pharmacol Exp Ther 2002;302(2):795-803.
16. Chowdhury PS, Gallo M, and Pastan I: Generation of high titer antisera in rabbits by DNA immunization. J Immunol Methods 2001;249(1-2):147-154.
17. Chen Y, Zhang T, Li T, Han W, Zhang Y, and Ma D: Preparation and characterization of a monoclonal antibody against CKLF1 using DNA immunization with in vivo electroporation. Hybridoma 2005;24(6):305-308.
18. Peterson NC, and Servinsky M: Characterization of the effects of Bcl-2 and Bcl-xl deletion mutant expression in cell lines used for antibody production. Hybridoma 2005;24(6):275-282.
19. Manickan E, Rouse RJ, Yu Z, Wire WS, and Rouse BT: Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J Immunol 1995;155(1):259-265.